Dtsch Arztebl Int
-
Randomized Controlled Trial
Decision Coaching for Healthy Women With BRCA1/2 Pathogenic Variants—Findings of the Randomized Controlled EDCP-BRCA Trial.
Women with pathogenic variants (PV) of the genes BRCA1/2 have a choice of preventive options. To help these women decide for themselves, we developed and implemented a decision coaching (DC) program and evaluated it for congruence between the participants' desired and actual roles in decision-making. ⋯ This DC program can help women who are carriers of BRCA1/2 PV participate actively in decision-making with regard to preventive measures.